This website uses cookies. By using our website you consent to all cookies in accordance with our Privacy Policy. Read more - OK, thanks

Back to Latest News

Monday 11 September 2017
G20 leaders make historic commitment to combat AMR and TB in Declaration

Heads of State and global leaders came together at the G20 Leaders’ Summit held in Hamburg, Germany on 7–8 July 2017. Dr Tedros Adhanom Ghebreyesus, WHO Director-General, led the WHO delegation participating in the G20 Summit. He met with heads of state and other high-level delegates to advocate for WHO priorities in global health. The 2017 G20 meeting for the first time included a comprehensive health track among its deliberations. The G20 Leaders’ Declaration – “Shaping an interconnected world” highlighted the importance of combatting antimicrobial resistance (AMR) including tuberculosis (TB) within its section on “Building Resilience” (see page 8-9),Specifically, TB was prioritized among other priority bacterial pathogens identified by WHO for which there is a critical need for fostering R&D. There was a call for a new international R&D Collaboration Hub to maximize the impact of existing and new antimicrobial basic and clinical research initiatives as well as product development. The Declaration also supported WHO´s central coordinating role in global health and response to health emergencies.

G20 Leaders’ Declaration is available here.